Peer Review History
| Original SubmissionJune 28, 2019 |
|---|
|
PONE-D-19-18168 Visual attention to emotional faces in adolescents with social anxiety disorder receiving cognitive behavioral therapy PLOS ONE Dear Dr Högström, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. I think both reviewers provided excellent critiques, and they should all be addressable. In particular, please develop on the concepts of avoidance and impaired disengagement in the introduction, as well as attention biases and vigilance, and make sure that you are consistent in the way you refer to these concepts throughout the manuscript. Give more clarifications regarding the details of the intervention, the interviews used, attrition rate, etc. Please provide information about how anxiety may have influenced the results, and their interpretation. We would appreciate receiving your revised manuscript by Sep 08 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Nouchine Hadjikhani, MD, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1) Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2) We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. 3) We note that Figure 1 in your submission may contain copyrighted images. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright. We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission: i) You may seek permission from the original copyright holder of Figure(s) [#] to publish the content specifically under the CC BY 4.0 license. We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text: “I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.” Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission. In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].” ii). If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: PONE-D-19-18168 The present manuscript describes a single study examining attention biases in adolescents diagnosed with SAD and a Non-Anxiety control group (NA) as well as the effect of the internet-based cognitive behavioural therapy on the attention biases in the clinical sample (pre-treatment, post- treatment and at a 6-month follow up). Attention biases examined by the study were vigilance to and disengagement from threatening stimuli as measured using eye tracking. To get at vigilance, the authors measured latency to reorient to the peripheral stimulus (emotional face) from the previously presented central stimulus (object) in the gap trials. Faster orienting to threatening stimulus during gap trials means better vigilance. To get at disengagement, the authors measured latency to orient to the peripheral stimulus (object) when presented along with the central stimulus (emotional face) in the overlap trials. Longer latency to disengage from the emotional face indexes impaired disengagement and faster disengagement would mean avoidance from threatening stimuli toward object. The results were: - No group differences in the gap trials with both groups orienting faster to angry than happy or neutral faces - No group differences in overlap trials both groups disengage faster from angry faces compared to happy and neutral - Those with SAD who had impaired disengagement at baseline had more social anxiety symptoms as measured by SPAI-C (POST AND 6 MONTHS) AND and CGI-S (AT 6MO), and presumably those with a more avoidant visual attention to faces resulted in less anxiety symptoms. Overall, I appreciated reading this paper because it separated the types of visual attention processes using an objective measure such as eye gaze. However, it was a bit difficult to find it very exciting since the results found no differences between the groups nor any significant changes after treatment. With that said, I do think the manuscript needs revision prior to publication. Based on my reading, I found several points that need adjusting, explanation and revision, some more major than others. I will point these out in the ‘chronological’ order of the manuscript. 1. In the abstract, it would be helpful for a reader to get a defining sentence of what types of attentional biases that are being examined. The authors say so on line 55, but I think a sentence stating it explicitly might be best. 2. Throughout the introduction I was confused by the relationship between vigilance avoidance and impaired disengagement. I was especially confused because avoidance and impaired disengagement seem to be two opposing processes (either short or long latency) but the actual limits are not clear – seems to be dependent on what is being measured in comparison. But because the authors focus their study on examining vigilance and impaired disengagement specifically, I would try to focus the introduction on those two concepts, with an extended information about the implications of impaired disengagement (what does that mean for those with anxiety disorders?). I understand that the reason why the authors talk about vigilance and avoidance is because of the past research linked those two together, but I think it tends to be confusing to the reader. Finally, the authors also refer to impaired disengagement differently using the term ‘disengagement/avoidance’ only in the discussion, but not anywhere else. Please be consistent. 3. Table 1 - The authors should consider whether the differences in a ADIS, MINI and SPAI should be added. 4. The ‘Intervention’ section on line to 34 page 11 is a bit unclear. Specifically, I am unclear on how many sessions the participants have had and whether the parental sessions were in addition to the nine participant sessions? Please clarify. Also, did all participants attend/complete all the parts of the treatment? 5. Results section - under the ‘Comparison between the SAD and NA groups’ Is it SAD baseline vs. NA? 6. Table 2 shows the number of participants in the SAD group baseline, post treatment and follow up. These numbers change significantly (n = 25 at baseline vs. n = 16 at 6-month follow up) Authors need to clear up why these numbers change. Attrition rate? Incomplete treatment? 7. Is there a way to see how many trials were completed by each group on average? 8. On page 19 line 417 the authors say are the latency was 2.2 but the table indicates 2.19 9. Throughout the paper, the authors go back and forth between saying stimulus is threatening (which I’m assuming means angry faces) to suggesting ALL social stimulus is being avoided (presumably because there were no main effect of emotion). It would be beneficial if the authors discussed more why all social stimuli (happy and neutral) faces could be regarded as potentially threatening to people with SAD or even adolescents with NA? 10. A big thumbs up for lines 520-525 pg. 24 of the Discussion! Reviewer #2: This study investigates the role of attention bias in youth with social anxiety disorder (SAD), and the association between attention bias and outcome following cognitive behavioral therapy (CBT) intervention. More specifically, the authors measured attention bias through vigilance to faces, as measured by latency to disengage attention from these social stimuli. First, attention bias was compared (at baseline) between non-anxious children and those with SAD; the authors found no group differences in disengagement from faces depicting various emotions. Second, the authors examined the relationship between attention disengagement from emotion faces with CBT outcome, and changes in attention bias following the CBT intervention. Results indicated that youth with SAD who showed a faster disengagement pattern had less anxiety following the intervention. There were no changes in attention bias following the intervention. The authors should address the following issues: Introduction: 1. The introduction would benefit from more comprehensive review of attention biases in anxiety, and SAD in particular, that extends beyond experimental findings. This would help set the stage for the importance of the study. 2. The introduction would benefit from some restructuring in terms of order of presented ideas. For example, it seems that review of attention bias across anxiety disorders (starting at line 104) should come before more specific review of this in SAD (starting at line 87). 3. What is the hypothesis for why vigilance to threat is moderated by age (lines 108-111)? May be helpful to discuss this in light of findings in Discussion. 4. Please cite definition of disengagement (lines 114-115). How does disengagement contribute to the development of SAD? A more thorough review is needed as this is the central conceptual framework of this study. Why is it important to assess all three aspects of attention; do you do this in the present study? 5. It seems that the authors use the term “vigilance” to mean faster latency to shift, and “avoidance” to mean slower disengagement, though this is not always clear/consistent in use of language. Consistency in how these concepts are referenced would be helpful throughout the manuscript (including in results). I find myself going back and forth through manuscript to “check” on what concept/process the authors are referencing. 6. “Children in the non-anxious group did not show any attention bias in any direction (line 128-129) – does this mean there were no differences in disengagement to faces by emotion type? 7. What is meant by “later stages of processing” (line 146)? 8. Please review what aspects of CBT, and especially ICBT, address attention bias at a basic attentional and emotional processing level (this would be helpful in Intro and again discussed in light of findings in the Discussion). 9. Why is vigilance toward threat predictive of greater symptom reduction (line 162-163)? 10. The authors may consider rephrasing “whether it is more beneficial” (line 169) to summarizing the link between the described bias and positive intervention outcome. Method: 1. The authors state that all SAD participants fulfilled DSM-5 criteria for a principal diagnosis of SAD in Participants section. May be helpful for clarification to include the name of the interview and that it was used for both groups (so the reader does not have to search for this info in Materials section). Relatedly, why were two structured interviews used in the SAD group used? 2. The authors have designed the experimental testing of attention bias through use of a gap-overlap task. It is unclear if the gap and overlap trials were run together or in separate blocks. 3. Additional citations are needed in the Experimental Paradigm section (e.g., lines 267-269; 271-275). Discussion 1. The Discussion section is opened with the “main purpose” of the study, which leaves out half of the research questions addressed. 2. Are there any differences in emotion stimuli used between this study and others in the literature? Could that have an impact on findings of no group differences in both gap and overlap tasks? 3. Is there some sort of developmental process in adolescence occurring that could account for lack of group differences between NA and SAD, especially in light of finding of differences during other developmental periods (childhood, adulthood)? 4. The authors don’t provide information on co-occurring anxiety diagnoses and this would be helpful. Could this impact the interpretation of results? For example, could co-occurring diagnosis (anxiety or otherwise) impact why there are no findings with regard prediction of treatment outcome or to changes in attention processes following treatment? Please address in Method/Discussion. 5. What could the potential impact be of ICBT intervention, versus more traditional in-person CBT, be on findings? For example, is there less emphasis on exposure, and could this impact the findings of no change in attentional processes post-treatment? Minor points to address: 1. The sentence, “One of the advantages…” (lines 101-103) is not clear. Eye tracking does not measure shifts “over time” as trials are averaged. Please clarify what is meant here. The sentence, “This practice has been established…” (lines 120-121) is not clear. Please rephrase to clarify point. 2. Please separate paragraph starting at line 118, starting with “ There are, however, few…. 3. There are several typos and manuscript needs to be proof read; for example, line 161 is missing youth “with” SAD. 4. Please identify that the numbers reported in Table 2 are in milliseconds. 5. Figures 3 & 4: Please consider adding indicators of significant results where they exist. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-19-18168R1 Visual attention to emotional faces in adolescents with social anxiety disorder receiving cognitive behavioral therapy PLOS ONE Dear Dr Högström, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. You will see that there are comments from a new reviewer, a statistician who was asked directly by PLoS to review your paper re: its statistical aspects. Please address these comments carefully, in addition to those still raised by one of the previous reviewers. We would appreciate receiving your revised manuscript by Nov 24 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Nouchine Hadjikhani, MD, PhD Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #2: Overall, the authors provided very helpful responses to the reviewer comments and the manuscript has benefitted substantially. Thank you for the thoughtful consideration of the points raised. Several additional/follow-up suggestions for revision follow: While the authors now define vigilance and avoidance in the Introduction, it is still somewhat confusing in the Abstract (especially with regard to vigilance). It is suggested that any definitions across Abstract and Introduction be consistent. The authors may consider changing use of “normally developed children” to “typically developing” or “non-anxious children” throughout the manuscript. Line 126: “looks to maintain” is not clear. While the definitions of vigilance and avoidance (lines 127-129) are helpful, additional clarity would be of benefit. It appears that vigilance is measured by orienting (toward threat – is this measured by Gap trials) and avoidance measured by disengagement (away from threat – is this measured by overlap trials). Perhaps these concepts could still be more clearly/concisely delineated throughout the manuscript. For example, no mention of vigilance in results (lines 400-409) – is this what was measured here? Lines 318-319: The use of “impaired disengagement” twice is redundant. Lines 485-487: Are these robust traits or are these not effectively targeted in the ICBT intervention (as outlined in lines 554-557)? Reviewer #3: The manuscript entitled 'Visual attention to emotional faces in adolescents with social anxiety disorder receiving cognitive behavioral therapy' with the aim to investigate the attention bias in youth with SAD and the association with outcome from CBT. This is quite an interesting study. The manuscript can be further improved based on the following comments. Methods Line 241, more information to be provided on 'population register'. Other information apart from Cohen'd, power 80% that was used to derive the calculated sample size to be stated e.g. group involved, alpha etc. Table 1, in the footnote, the specific t test to be named. the word 'test' to be added for chi-square. The name of the statistical software including the version and publisher name that was used for the data analysis to be stated. The acceptance level of significance to be stated. Results The word significant to be added to the word difference(s) and other related interpretation in the results and discussion section where applicable. Table 1 and Figure 1,2,3,4 size to be enlarged as it is difficult for the reader to visualize. For all F statistics presentation, the dfs between them to be separated with a space after comma. Line 411, the post hoc analyses refers to, with or without correction? This to be stated in the statistical analyses section. Line 392 - 448, all these results could be displayed in one table form but with different section according to the domains for easy visualization. Symbol =< to be replaced with ≤ Table 3, BF01 and BF10 to be clearly defined in the footnote. It would be good to illustrate for the reader one example how the BF value was obtained including BF formula and changes (Δ) in BIC. Figure 3 and 4, error bar and n to be stated. Some references did not conform to the journal format. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Visual attention to emotional faces in adolescents with social anxiety disorder receiving cognitive behavioral therapy PONE-D-19-18168R2 Dear Dr. Högström, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Nouchine Hadjikhani, MD, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-19-18168R2 Visual attention to emotional faces in adolescents with social anxiety disorder receiving cognitive behavioral therapy Dear Dr. Högström: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Prof. Nouchine Hadjikhani Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .